Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Neoplasms 2Depression 2Pancreatic Neoplasms 1Lymphoma, Follicular 1Dignity 1Depressive Disorder 1Dementia 1Death 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Dignity Therapy × Clear all
NCT06105359 2026-04-09

The Effect of Dignity Therapy Applied to Cancer Patients

Necmettin Erbakan University

Phase NA Completed
48 enrolled

Depression, Neoplasms

NCT01507571 2012-01-11

DignityDK

Bispebjerg Hospital

Phase 2 Completed
80 enrolled

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡